SEIDLER; Randolph

Patent Applications and Registrations

Patent applications and USPTO patent grants for SEIDLER; Randolph.The latest application filed is for "1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-- piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal".

Company Profile

0.7.21

SEIDLER; Randolph - Eckenroth DE
Seidler; Randolph - Sandy Hook CT US
Seidler; Randolph - Danbury CT
Seidler; Randolph - Mittelbiberach DE
Seidler, Randolph - Biberach DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-- Piperidin-1-yl]-xanthine For The Treatment Of A Metabolic Disorder Of A Predominantly Carnivorous Non-human Animal App 20160346288 - DE VRIES; Frerich ; et al.	2016-12-01
Taste masked pharmaceutical composition Grant 9,289,390 - Folger , et al. March 22, 2	2016-03-22
1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-- Piperidin-1-yl]-axanthine For The Treatment Of A Metabolic Disorder Of A Predominantly Carnivorous Non-human Animal App 20140228287 - DE VRIES; Frerich ; et al.	2014-08-14
Taste Masked Pharmaceutical Composition App 20140227351 - FOLGER; Martin ; et al.	2014-08-14
Funny Current (if) Inhibitors For Use In A Method Of Treating And Preventing Heart Disease In Canine App 20140171415 - KLEY; Saskia ; et al.	2014-06-19
Taste masked pharmaceutical composition Grant 8,741,350 - Folger , et al. June 3, 2	2014-06-03
Use of a Specific Cyclic Amine Derivative or the Pharmaceutically Acceptable Salts Thereof for the Treatment or Prevention of Heart Failure App 20130317008 - GUTH; Brian ; et al.	2013-11-28
Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure Grant 8,524,701 - Guth , et al. September 3, 2	2013-09-03
Taste Masked Pharmaceutical Composition App 20130084332 - FOLGER; Martin ; et al.	2013-04-04
Inhibitors For Treating And Preventing Heart Failure In Felines App 20130040937 - Albrecht; Balazs ; et al.	2013-02-14
1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-- Piperidin-1-yl]-xanthine For The Treatment Of A Metabolic Disorder Of A Predominantly Carnivorous Non-human Animal App 20110237532 - DE VRIES; Frerich ; et al.	2011-09-29
Use Of A Specific Cyclic Amine Derivative Or The Pharmaceutically Acceptable Salts Thereof For The Treatment Or Prevention Of Heart Failure App 20080312210 - GUTH; Brian ; et al.	2008-12-18
Use Of Bradycardiac Substances In The Treatment Of Myocardial Diseases Associated With Hypertrophy And Novel Medicament Combinations App 20070155679 - Daemmgen; Juergen ; et al.	2007-07-05
Use Of A Specific Cyclic Amine Derivative Or The Pharmaceutically Acceptable Salts Thereof For The Treatment Or Prevention Of Heart Failure App 20070142354 - Guth; Brian ; et al.	2007-06-21
Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations Grant 7,208,508 - Daemmgen , et al. April 24, 2	2007-04-24
Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure App 20060063840 - Guth; Brian ; et al.	2006-03-23
Method for the production of an N-terminally modified chemotactic factor App 20050148507 - Wandl, Robert ; et al.	2005-07-07
Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure App 20040138306 - Guth, Brian ; et al.	2004-07-15
Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations App 20040014795 - Daemmgen, Juergen ; et al.	2004-01-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.